Pacific Edge Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pacific Edge Limited with three other
miscellaneous service companies in Australasia:
Innate Immunotherapeutics Ltd
sales of 1.83 million Australian Dollars [US$1.46 million]
8I Holdings Ltd
(15.46 million Australian Dollars [US$12.30 million]
of which 86%
was Singapore Investment in private markets), and
Ibosses Corporation Ltd
based in Australia
(2.25 million Australian Dollars [US$1.79 million]
Pacific Edge Limited reported sales of 8.06 million New Zealand Dollars (US$5.93 million)
March of 2017.
increase of 62.0%
versus 2016, when the company's sales were 4.98 million New Zealand Dollars.
This was the fourth straight year of sales growth at Pacific Edge Limited.
Sales of Us Laboratory saw an increase
67.7% in 2017, from
4.63 million New Zealand Dollars to 7.77 million New Zealand Dollars.
Not all segments of Pacific Edge Limited experienced an increase in sales in 2017:
sales of Nz Laboratory fell 13.8% to 296,623.00 New Zealand Dollars.